Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends

Abstract Aims The risk of HeartMate II (HMII) left ventricular assist device (LVAD) thrombosis has been reported, and serum lactate dehydrogenase (LDH), a biomarker of haemolysis, increases secondary to LVAD thrombosis. This study evaluated longitudinal measurements of LDH post‐LVAD implantation, hy...

Descrición completa

Detalles Bibliográficos

Principais autores:	Thomas E. Hurst, Andrew Xanthopoulos, John Ehrlinger, Jeevanantham Rajeswaran, Amol Pande, Lucy Thuita, Nicholas G. Smedira, Nader Moazami, Eugene H. Blackstone, Randall C. Starling
Formato:	Artigo
Idioma:	Inglês
Publicado:	Oxford University Press 2019-10-01
Series:	ESC Heart Failure
Assuntos:	Pump thrombosis Left ventricular assist device Lactate dehydrogenase Biomarker
Acceso en liña:	https://doi.org/10.1002/ehf2.12473
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!